209 related articles for article (PubMed ID: 22432718)
1. Application of advanced in silico methods for predictive modeling and information integration.
Valerio LG
Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):395-8. PubMed ID: 22432718
[TBL] [Abstract][Full Text] [Related]
2. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
[TBL] [Abstract][Full Text] [Related]
3. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
4. Predictive computational toxicology to support drug safety assessment.
Valerio LG
Methods Mol Biol; 2013; 930():341-54. PubMed ID: 23086849
[TBL] [Abstract][Full Text] [Related]
5. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
6. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.
Sutter A; Amberg A; Boyer S; Brigo A; Contrera JF; Custer LL; Dobo KL; Gervais V; Glowienke S; van Gompel J; Greene N; Muster W; Nicolette J; Reddy MV; Thybaud V; Vock E; White AT; Müller L
Regul Toxicol Pharmacol; 2013 Oct; 67(1):39-52. PubMed ID: 23669331
[TBL] [Abstract][Full Text] [Related]
7. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens.
Jacobson-Kram D; Contrera JF
Toxicol Sci; 2007 Mar; 96(1):16-20. PubMed ID: 17194803
[TBL] [Abstract][Full Text] [Related]
8. Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives.
Benfenati E; Benigni R; Demarini DM; Helma C; Kirkland D; Martin TM; Mazzatorta P; Ouédraogo-Arras G; Richard AM; Schilter B; Schoonen WG; Snyder RD; Yang C
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):57-90. PubMed ID: 19412856
[TBL] [Abstract][Full Text] [Related]
9. What's next after 50 years of psychiatric drug development: an FDA perspective.
Laughren TP
J Clin Psychiatry; 2010 Sep; 71(9):1196-204. PubMed ID: 20923624
[TBL] [Abstract][Full Text] [Related]
10. Role of in silico genotoxicity tools in the regulatory assessment of pharmaceutical impurities.
Fioravanzo E; Bassan A; Pavan M; Mostrag-Szlichtyng A; Worth AP
SAR QSAR Environ Res; 2012; 23(3-4):257-77. PubMed ID: 22369620
[TBL] [Abstract][Full Text] [Related]
11. Latest advances in computational genotoxicity prediction.
Naven RT; Greene N; Williams RV
Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1579-87. PubMed ID: 22998164
[TBL] [Abstract][Full Text] [Related]
12. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
Valerio LG; Cross KP
Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
[TBL] [Abstract][Full Text] [Related]
13. Integrated decision support for assessing chemical liabilities.
Spjuth O; Eklund M; Ahlberg Helgee E; Boyer S; Carlsson L
J Chem Inf Model; 2011 Aug; 51(8):1840-7. PubMed ID: 21774475
[TBL] [Abstract][Full Text] [Related]
14. Validation of Toxtree and SciQSAR in silico predictive software using a publicly available benchmark mutagenicity database and their applicability for the qualification of impurities in pharmaceuticals.
Contrera JF
Regul Toxicol Pharmacol; 2013 Nov; 67(2):285-93. PubMed ID: 23969001
[TBL] [Abstract][Full Text] [Related]
15. Testing computational toxicology models with phytochemicals.
Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
[TBL] [Abstract][Full Text] [Related]
16. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
Paciorek CJ; Liu Y;
Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
[TBL] [Abstract][Full Text] [Related]
17. In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey.
Dobo KL; Greene N; Fred C; Glowienke S; Harvey JS; Hasselgren C; Jolly R; Kenyon MO; Munzner JB; Muster W; Neft R; Reddy MV; White AT; Weiner S
Regul Toxicol Pharmacol; 2012 Apr; 62(3):449-55. PubMed ID: 22321701
[TBL] [Abstract][Full Text] [Related]
18. Computational science in drug metabolism and toxicology.
Valerio LG
Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):781-4. PubMed ID: 20465524
[TBL] [Abstract][Full Text] [Related]
19. Crowd computing: using competitive dynamics to develop and refine highly predictive models.
Bentzien J; Muegge I; Hamner B; Thompson DC
Drug Discov Today; 2013 May; 18(9-10):472-8. PubMed ID: 23337388
[TBL] [Abstract][Full Text] [Related]
20. Predictive in silico off-target profiling in drug discovery.
Schmidt F; Matter H; Hessler G; Czich A
Future Med Chem; 2014 Mar; 6(3):295-317. PubMed ID: 24575966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
